<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>24</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Optimizing bolus application in postmastectomy radiotherapy: A dosimetric study on the impact of frequency and reoptimization</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-justify:newspaper&quot;&gt;&lt;span style=&quot;text-kashida-space:50%&quot;&gt;&lt;span style=&quot;line-height:119%&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;This study assessed the dosimetric implications of a reduced-frequency bolus regimen combined with treatment plan reoptimization in post-mastectomy radiotherapy (PMRT), with the goal of optimizing target coverage and organ-at-risk (OAR) dose sparing. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Eighteen post-mastectomy patients scheduled for radiotherapy were enrolled. CT simulation was performed without bolus. A baseline plan (Plan(all)) was created using a virtual bolus to meet clinical objectives. Two derivative plans were generated from Plan(all): Plan (nobolus)- direct bolus removal without re-optimization and Plan(nobolus-new)- re-optimized after bolus removal to enhance target coverage. Three hybrid 25-fraction plans were generated by combining fractions of Plan(all) and Plan (nobolus): Plan(20bolus) (20 fractions Plan(all)+5 fractions Plan(nobolus)), Plan(18bolus)(18+7), and Plan(13bolus)(13+12). Similarly, three additional hybrid plans were constructed by combining Plan(all) with Plan(nobolus-new): Plan(20bolus-new), Plan(18bolus-new) and Plan(13bolus-new). Dosimetric parameters were compared across all plans. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Compared with Plan(nobolus), Plan(nobolus-new) offered improved target coverage, reduced high-dose volumes within the target, and enhanced dose homogeneity, albeit at the expense of elevated doses to the lungs, heart, and skin. Notably, Plan(13bolus-new) achieved comparable skin dose (body2mm/D10cc: 50.19&amp;plusmn;1.33 Gy vs 50.19&amp;plusmn;0.46 Gy, P&gt;0.05) and high-dose target volume (PTV/D2%: 52.95&amp;plusmn;0.25 Gy vs 52.99&amp;plusmn;0.20 Gy, P&gt;0.05) relative to the Plan(20bolus), while yielding statistically superior target coverage (PTV/V95%p: 96.59&amp;plusmn;1.86% vs 97.36 &amp;plusmn;1.53%, P&lt;0.05). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;A reduction in bolus application frequency compromises target coverage yet attenuates skin dose. A strategy combining reduced bolus frequency with plan reoptimization represents a feasible approach to minimize bolus use while preserving both target coverage and skin dose parameters.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Post-radical mastectomy radiotherapy, bolus, plan design, plan dosimetry.</keyword>
	<start_page>509</start_page>
	<end_page>514</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-1526&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Z. </first_name>
	<middle_name></middle_name>
	<last_name>Shan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460033657</code>
	<orcid>7900319475328460033657</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiotherapy, Luohu People’s Hospital, Shenzhen, 518000, China </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F. </first_name>
	<middle_name></middle_name>
	<last_name>Zhou</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fszl2025@163.com </email>
	<code>7900319475328460033658</code>
	<orcid>7900319475328460033658</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiotherapy, Luohu People’s Hospital, Shenzhen, 518000, China </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
